Insider · CIK 0001242992

CLACKSON TIMOTHY P

Reports to the SEC for 6 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001242992

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.2K sh	—	—	0
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2025-07-23	Elevation Oncology, Inc.U Disposition from Tender	Director	UDisposition from Tender	−47.3K sh	$0.36	−$17K	0
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.6K sh	—	—	0
2025-06-05	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2024-06-13	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2023-09-01	Elevation Oncology, Inc.G Gift	Director	GGift	−15.8K sh	—	—	0
2023-06-16	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+31.2K sh	—	—	31,238
2023-03-01	Theseus Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director, President and CEO	AAward	+45.6K sh	—	—	45,625
2023-02-17	Theseus Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+274K sh	—	—	273,750
2022-11-11	Theseus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+2,500 sh	$6.80	+$17K	351,030
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.U Disposition from Tender	Director	UDisposition from Tender	−7,250 sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28.1K sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,750 sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.U Disposition from Tender	Director	UDisposition from Tender	−23.6K sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,375 sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,351 sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.5K sh	—	—	0
2022-06-17	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.6K sh	—	—	15,619
2022-06-08	Forma Therapeutics Holdings, Inc.A Award	Director	AAward	+4,500 sh	—	—	30,840
2022-06-08	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,750 sh	—	—	6,750
2022-05-31	Elevation Oncology, Inc.G Gift	Director	GGift	−31.6K sh	—	—	15,777
2022-02-18	Theseus Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+450K sh	—	—	450,000
2021-12-21	Theseus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+2,600 sh	$9.76	+$25.4K	348,530
2021-06-17	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+8,375 sh	—	—	8,375
2021-06-17	Forma Therapeutics Holdings, Inc.A Award	Director	AAward	+2,750 sh	—	—	26,340
2020-09-30	F-star Therapeutics, Inc.A Award	Director	AAward	+9,422 sh	—	—	50,486
2020-06-30	F-star Therapeutics, Inc.A Award	Director	AAward	+8,588 sh	—	—	41,064
2020-06-24	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-06-23	Forma Therapeutics Holdings, Inc.S Sale	Director	SSale	−35.1K sh	—	—	0
2020-06-23	Forma Therapeutics Holdings, Inc.P Purchase	Director	PPurchase	+23.6K sh	—	—	23,590
2020-06-18	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	0
2020-03-31	F-star Therapeutics, Inc.A Award	Director	AAward	+13.6K sh	—	—	32,476
2019-12-31	F-star Therapeutics, Inc.A Award	Director	AAward	+7,991 sh	—	—	18,901
2019-09-30	F-star Therapeutics, Inc.A Award	Director	AAward	+3,670 sh	—	—	10,910
2019-07-10	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2019-06-28	F-star Therapeutics, Inc.A Award	Director	AAward	+3,421 sh	—	—	7,240
2019-03-29	F-star Therapeutics, Inc.A Award	Director	AAward	+1,204 sh	—	—	3,819
2019-01-02	F-star Therapeutics, Inc.A Award	Director	AAward	+1,083 sh	—	—	2,615
2018-10-01	F-star Therapeutics, Inc.A Award	Director	AAward	+788 sh	—	—	1,532
2018-07-02	F-star Therapeutics, Inc.A Award	Director	AAward	+744 sh	—	—	744
2018-03-01	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-02-16	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	President, R&D, CSO	DDisposition to Issuer	−14.6K sh	—	—	0
2017-02-16	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	President, R&D, CSO	DDisposition to Issuer	−73K sh	—	—	0
2017-02-16	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	President, R&D, CSO	DDisposition to Issuer	−87.1K sh	—	—	0
2017-02-16	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	President, R&D, CSO	DDisposition to Issuer	−65K sh	—	—	0
2017-02-16	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	President, R&D, CSO	DDisposition to Issuer	−82K sh	—	—	0
2017-02-16	ARIAD PHARMACEUTICALS INCD Disposition to Issuer	President, R&D, CSO	DDisposition to Issuer	−577 sh	—	—	0

Recent filings

Accepted (ET)
Jul 244
CLACKSON TIMOTHY P0001415889-25-020238
SEC(opens sec.gov)
Jun 94
CLACKSON TIMOTHY P0001415889-25-016237
SEC(opens sec.gov)
Jun 174
CLACKSON TIMOTHY P0001415889-24-017193
SEC(opens sec.gov)
Sep 54
CLACKSON TIMOTHY P0001415889-23-012907
SEC(opens sec.gov)
Jun 214
CLACKSON TIMOTHY P0001415889-23-010092
SEC(opens sec.gov)
Mar 24
CLACKSON TIMOTHY P0001104659-23-027622
SEC(opens sec.gov)
Feb 214
CLACKSON TIMOTHY P0001104659-23-023504
SEC(opens sec.gov)
Nov 144
CLACKSON TIMOTHY P0001104659-22-118549
SEC(opens sec.gov)
Oct 144
CLACKSON TIMOTHY P0000899243-22-033647
SEC(opens sec.gov)

Companies

Address

C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139